CD74 Is Expressed in Relapsed and Refractory Multiple Myeloma and Can be Targeted with a Novel Anti-CD74 Antibody Drug Conjugate, STRO-001

被引：0
|
作者：
Embry, Millicent
Li, Xiaofan
Yu, Abigail
Abrahams, Cristina
Greenland, Nancy Y.
Wen, Kwun Wah
Jones, Chris
DeAlmeida, Venita
Krimm, Stellanie
Krueger, Sarah
Matheny, Shannon
Kline, Toni
Yam, Alice
Stafford, Ryan
Wiita, Arun P.
Hallam, Trevor
Lupher, Mark
Molina, Arturo
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4420
引用
收藏
页数：3
相关论文
共 50 条
  • [31] SGN-CD48A: a Novel Humanized Anti-CD48 Antibody-Drug Conjugate for the Treatment of Multiple Myeloma
    Lewis, Tim S.
    Olson, Devra
    Gordon, Kristine
    Sandall, Sharsti
    Quick, Marsha
    Finn, Margo
    Westendorf, Lori
    Linares, Germein
    Leiske, Chris
    Nesterova, Albina
    Huang, Lanshan
    Goswami, Maitrayee
    Wang, Sa
    Law, Che-Leung
    BLOOD, 2016, 128 (22)
  • [32] CD25-targeted antibody–drug conjugate camidanlumab tesirine for relapsed or refractory classical Hodgkin lymphoma
    Bo Xu
    Shaoqian Li
    Bo Kang
    Shangzhi Fan
    Zunbo He
    Jiecan Zhou
    Investigational New Drugs, 2022, 40 : 1333 - 1341
  • [33] Effective therapy of human lymphoma xenografts with a novel recombinant ribonuclease/anti-CD74 humanized IgG4 antibody immunotoxin
    Chang, CH
    Sapra, P
    Vanama, SS
    Hansen, HJ
    Horak, ID
    Goldenberg, DM
    BLOOD, 2005, 106 (13) : 4308 - 4314
  • [34] CD25-targeted antibody-drug conjugate camidanlumab tesirine for relapsed or refractory classical Hodgkin lymphoma
    Xu, Bo
    Li, Shaoqian
    Kang, Bo
    Fan, Shangzhi
    He, Zunbo
    Zhou, Jiecan
    INVESTIGATIONAL NEW DRUGS, 2022, 40 (06) : 1333 - 1341
  • [35] BT062, An Antibody-Drug Conjugate Directed Against CD138, Shows Clinical Activity in Patients with Relapsed or Relapsed/Refractory Multiple Myeloma
    Jagannath, Sundar
    Chanan-Khan, Asher
    Heffner, Leonard T.
    Avigan, David
    Zimmerman, Todd M.
    Lonial, Sagar
    Lutz, Robert J.
    Engling, Andre
    Uherek, Christoph
    Osterroth, Frank
    Ruehle, Markus
    Beelitz, Michelle A.
    Niemann, Gabriele
    Wartenberg-Demand, Andrea
    Haeder, Thomas
    Anderson, Kenneth C.
    Munshi, Nikhil C.
    BLOOD, 2011, 118 (21) : 142 - 143
  • [36] Targeting CD74 with Novel Antibody Drug Conjugates (ADCs) for the Treatment of B-Cell Non-Hodgkin's Lymphoma (NHL)
    Li, Xiaofan
    Abrahams, Cristina
    Embry, Millicent
    Yu, Abigail
    Kahana, Jason
    Brown, Michael
    Narla, Rama Krishna
    Barnes, Leo
    Schwartz, Eric
    Boylan, John
    Zawada, James
    Stephenson, Heather
    Bruhns, Maureen
    Bussell, Stuart
    Steiner, Alexander
    Galan, Adam
    Kline, Toni
    Yam, Alice
    Stafford, Ryan
    Hoffmann, Heidi
    Matheny, Shannon
    DeAlmeida, Venita
    Vasquez, Nicki
    Heinsohn, Henry
    Sato, Aaron
    Molina, Arturo
    Hallam, Trevor
    Lupher, Mark, Jr.
    BLOOD, 2016, 128 (22)
  • [37] A phase I-II clinical trial of the anti-CD74 monoclonal antibody milatuzumab in frail patients with refractory chronic lymphocytic leukaemia: A patient based approach
    Haran, Michal
    Mirkin, Vita
    Braester, Andrei
    Harpaz, Nurith
    Shevetz, Olga
    Shtreiter, Marina
    Greenberg, Shulamit
    Mordich, Orly
    Amram, Orna
    Binsky-Ehrenreich, Inbal
    Marom, Ayelet
    Shachar, Idit
    Herishanu, Yair
    Ruchlemer, Rosa
    Berrebi, Alain
    Valinsky, Liora
    Shtalrid, Mordechai
    Shvidel, Lev
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 182 (01) : 125 - 128
  • [38] Construction and characterization of a novel ribonuclease immunotoxin consisting of two ranpirnase (Rap) molecules fused to an internalizing anti-CD74 humanized IgG4 antibody
    Vanama, SS
    Sapra, P
    Hansen, HJ
    Horak, ID
    Goldenberg, DM
    Chang, CH
    BLOOD, 2004, 104 (11) : 899A - 899A
  • [39] Phase 1 study of the anti-BCMA antibody-drug conjugate AMG 224 in patients with relapsed/refractory multiple myeloma
    Hans C. Lee
    Noopur S. Raje
    Ola Landgren
    Vijay V. Upreti
    Jin Wang
    Ariel A. Avilion
    Xuguang Hu
    Erik Rasmussen
    Gataree Ngarmchamnanrith
    Hisaki Fujii
    Andrew Spencer
    Leukemia, 2021, 35 : 255 - 258
  • [40] BT062, An Antibody-Drug Conjugate Directed Against CD138, Shows Clinical Activity In a Phase I Study in Patients with Relapsed or Relapsed/Refractory Multiple Myeloma
    Jagannath, Sundar
    Chanan-Khan, Asher A.
    Heffner, Leonard T.
    Avigan, David
    Lutz, Robert J.
    Uherek, Christoph
    Osterroth, Frank
    Ruehle, Markus
    Haeder, Thomas
    Niemann, Gabriele
    Wartenberg-Demand, Andrea
    Munshi, Nikhil C.
    Anderson, Kenneth C.
    BLOOD, 2010, 116 (21) : 1262 - 1262
12345